NewAmsterdam Pharma Co N.V.
NAMSW—
NewAmsterdam Pharma Co N.V.NAMSW$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-1.72
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$22.50M
Net income
$-203.82M
Net margin
-905.7%
Gross margin
—
Dividends & financials
NewAmsterdam Pharma Co N.V. (NAMSW) reported revenue of $22.50M and net income of $-203.82M, or $-1.72 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.